Clinical trial achieved all three primary objectives with no significant safety issues being reported. Results indicate that Emrosi can be safely used for up to 16 weeks with no d ...
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback